Almost two years after remdesivir was approved and extensively used in numerous clinical
studies for the treatment of COVID-19 patients, there is still no clear recommendation for the …

Background Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro
and efficacy in animal models of coronavirus disease 2019 (Covid-19). Methods We …

The therapeutic options for COVID-19 patients are currently limited, but numerous
randomized controlled trials are being completed, and many are on the way. For COVID-19 …

Introduction: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is well known
as a novel member of the coronavirus family which caused a sudden outbreak of …

There are different therapeutics options to treat COVID-19 at different stages of the disease.
While large-scale prophylaxis in the general population now relies on vaccination, antiviral …

Background Remdesivir is approved by the US Food and Drug Administration for the
treatment of patients hospitalized with coronavirus disease 2019 (COVID-19) and has been …

Background and Objectives: The therapeutic impact of remdesivir on hospitalized adult
COVID-19 patients is unknown. The purpose of this meta-analysis was to compare the …

Coronavirus Disease (COVID-19) pandemic has affected more than seven million
individuals in 213 countries worldwide with a basic reproduction number ranging from 1.5 to …

Objectives This study investigated remdesivir's clinical use to provide direct evidence of
effectiveness for a low-middle income Asian setting. Design A one-to-one propensity score …

Background There is an urgent need to understand the real-world effectiveness of
remdesivir in the treatment of SARS-CoV-2. Methods This was a retrospective comparative …